Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
NI-1701 by Light Chain Bioscience for Chronic Lymphocytic Leukemia (CLL): Likelihood of Approval
NI-1701 is under clinical development by Light Chain Bioscience and currently in Phase I for Chronic Lymphocytic Leukemia (CLL). According...
NI-1701 by Light Chain Bioscience for Follicular Lymphoma: Likelihood of Approval
NI-1701 is under clinical development by Light Chain Bioscience and currently in Phase I for Follicular Lymphoma. According to GlobalData,...
NI-1701 by Light Chain Bioscience for B-Cell Non-Hodgkin Lymphoma: Likelihood of Approval
NI-1701 is under clinical development by Light Chain Bioscience and currently in Phase I for B-Cell Non-Hodgkin Lymphoma. According to...